Chronic motion sickness patients could be helped by the Reliefband, a wearable that uses pulses to block signals entering the part of the brain related to nausea. 

More than 30 million people suffer from chronic motion sickness and experience nausea or vertigo when traveling. The U.S. Food and Drug Administration-cleared Reliefband wearable uses the body’s own neural pathways to control nausea. The wearable delivers pulses to the media nerve at the pressure point at the underside of the wrist. These pulses send signals to the nausea center of the brain to alleviate symptoms for patients.

“Since 2014, the company has demonstrated the viability of our technology in the over-the-counter healthcare market by significantly growing unit and dollar sales,” according to Nick Spring, president and CEO of Reliefband Technologies. “Reliefband Technologies has primarily focused on direct-to-consumer online distribution, and recently, due to uplifting demand has selectively increased distribution in specialty retail environments. Given the rapid increase in wearable technology and consumers desiring to manage their health without medications, new approaches like ours are on the forefront of helping those in need.”